Absorption |
Blood-Brain Barrier | BBB+ | 0.6461 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7078 |
P-glycoprotein Substrate | Substrate | 0.7753 |
P-glycoprotein Inhibitor | Inhibitor | 0.6720 |
Inhibitor | 0.8877 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6480 |
Distribution |
Subcellular localization | Mitochondria | 0.4779 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6553 |
CYP450 2D6 Substrate | Substrate | 0.8918 |
CYP450 3A4 Substrate | Substrate | 0.7254 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8230 |
CYP450 2C9 Inhibitor | Inhibitor | 0.6864 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8394 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8222 |
CYP450 3A4 Inhibitor | Inhibitor | 0.8490 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5839 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8664 |
Inhibitor | 0.7602 |
AMES Toxicity | Non AMES toxic | 0.5683 |
Carcinogens | Non-carcinogens | 0.6658 |
Fish Toxicity | High FHMT | 0.9939 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8865 |
Honey Bee Toxicity | Low HBT | 0.6694 |
Biodegradation | Not ready biodegradable | 0.7641 |
Acute Oral Toxicity | III | 0.5445 |
Carcinogenicity (Three-class) | Non-required | 0.6134 |